Novel Approaches to Assessing Cardiac Safety - Proceedings of a Workshop: Regulators, Industry and Academia Discuss the Future of In Silico Cardiac Modelling to Predict the Proarrhythmic Safety of Drugs

Author： Fletcher Katherine  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.5, 2011-05, pp. : 439-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles  

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Cardiac safety of venlafaxine

By Danjou P.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 307-308

Elsevier

Access to resources Recommend Favorite

Cardiac safety of sunitinib questioned

By  

Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cardiac safety strategies

By Hanton Gilles   Tilbury Lorraine  

Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. : 329-333

Informa Healthcare

Access to resources Recommend Favorite

Cardiac Repolarisation and Drug Regulation: Assessing Cardiac Safety 10 Years after the CPMP Guidance

By Shah Rashmi R.  

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1093-1110

Adis International

Access to resources Recommend Favorite